Table 2 Demographics and baseline characteristics of patients with increases/no change or decreases from baseline in HDL-C at endpoint
HDL-C increase and no change | HDL-C decrease | All patients | |
|---|---|---|---|
Demographic Parameters | |||
Mean age ± SD, years (n) | 54.6 ± 10.3 (715) | 52.6 ± 10.8 (139) | 54.3 ± 10.4 (854) |
<65 years, n (%) | 578 (80.8%) | 122 (87.8%) | 700 (82.0%) |
≥65 years, n (%) | 137 (19.2%) | 17 (12.2%) | 154 (18.0%) |
Gender, n (%) | |||
Female | 340 (47.6%) | 57 (47.6%) | 397 (46.5%) |
Male | 375 (52.4%) | 82 (59.0%) | 457 (53.5%) |
Race category, n (%) | |||
Caucasian | 561 (78.5%) | 111 (79.9%) | 672 (78.7%) |
Non-Caucasian | 154 (21.5%) | 28 (20.1%) | 182 (21.3%) |
History of diabetes, n (%) | 86 (12.0%) | 20 (14.4%) | 106 (12.4%) |
Baseline Parameters, mmol/L (n) | |||
Mean HDL ± SD | 1.1 ± 0.2 (715) | 1.2 ± 0.3 (139) | 1.1 ± 0.2 (854) |
Mean Apo AI ± SD (g/L) | 1.5 ± 0.2 (706) | 1.6 ± 0.4 (134) | 1.5 ± 0.3 (840) |
Mean LDL-C ± SD | 4.2 ± 0.7 (715) | 4.2 ± 0.7 (139) | 4.2 ± 0.7 (854) |
Mean Apo B ± SD (g/L) | 1.7 ± 0.2 (706) | 1.6 ± 0.3 (134) | 1.6 ± 0.2 (840) |
Mean Non-HDL-C ± SD | 5.6 ± 0.8 (715) | 5.4 ± 0.8 (139) | 5.6 ± 0.8 (854) |
Mean TC ± SD | 6.7 ± 0.9 (715) | 6.6 ± 0.8 (139) | 6.7 ± 0.8 (854) |
Median TG ± SD | 2.9 ± 1.0 (715) | 2.7 ± 1.1 (139) | 2.9 ± 1.0 (854) |